Table 1.
Baseline characteristics (general)
Fluvoxamine N = 17 | Placebo N = 16 | P-value | |
Male/Female | 4/13 | 6/10 | 0.38 |
PBC/PSC | 12/5 | 10/6 | 0.57 |
Age (median) | 51 | 54 | 0.38 |
Pruritus (yes/no) | 9/8 | 8/8 | 0.87 |
UDCA dose (median, mg/day) | 750 | 900 | 0.14 |
Previous depressive disorder (yes/no) | (0/17) | (1/15) | 0.30 |
Weight (median, kg) | 67 | 71 | 0.95 |
Length (median, cm) | 173 | 171 | 0.67 |
Body Mass Index (median) | 24.2 | 24.6 | 0.61 |
Haemoglobin (mmol/l, median) | 8.3 | 8.8 | 0.21 |
Bilirubin (μmol/l, median) | 13 | 11.5 | 0.83 |
Alkaline Phosphatase (U/l, median) | 137 | 192 | 0.36 |
ALT (U/l, median) | 42 | 43 | 0.55 |
Albumin (U/l, median) | 42 | 41.5 | 0.81 |
Laboratory reference values: haemoglobin 7.5–9.5 mmol/l, bilirubin 0–16 μmol/l, alkaline phosphatase 0–119 U/l, ALT 0–30 U/l, albumin 35–50 g/l.